​

Funding Round

Series D - Biofourmis

Series D - Biofourmis

Investment Firm

Overview

Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.

Announced Date

Apr 26, 2022

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

General Atlantic

General Atlantic

General Atlantic is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

4

Investor Name
Participant InvestorOpenspace
Participant InvestorEDBI
Participant InvestorGeneral Atlantic
Participant InvestorCVS Health

Round Details and Background

Biofourmis raised $300000000 on 2022-04-26 in Series D

Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 26, 2022
Series D - Biofourmis
4-300.0M
Jul 27, 2022
Series D - Biofourmis
1-20.0M
Aug 10, 2016
Angel Round - Biofourmis
2-1.0M
Dec 01, 2015
Angel Round - Biofourmis
1-71.1K

Recent Activity

There is no recent news or activity for this profile.